Use of phenytoin and other anticonvulsant prophylaxis in patients with aneurysmal subarachnoid hemorrhage [9]

Stroke

Volumn 36, Issue 12, 2005, Pages 2532-

  Wong, George K C ^a   Poon, W S ^a  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICONVULSIVE AGENT; CARBAMAZEPINE; CYTOCHROME P450 3A4; NIMODIPINE; PHENOBARBITAL; PHENYTOIN; VALPROIC ACID;

ANEURYSM CLIP; BLEEDING; BRAIN ARTERY ANEURYSM; BRAIN ISCHEMIA; COGNITIVE DEFECT; CRANIOTOMY; DRUG ANTAGONISM; DRUG BIOAVAILABILITY; DRUG CHOICE; DRUG CLEARANCE; DRUG METABOLISM; FIRST PASS EFFECT; HIGH RISK PATIENT; HUMAN; INTERVIEW; LETTER; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROPHYLAXIS; SEIZURE; SUBARACHNOID HEMORRHAGE; TABLET; THROMBOCYTE AGGREGATION; THROMBOCYTOPENIA; CHEMICALLY INDUCED DISORDER; DRUG INTERACTION; INTRACRANIAL ANEURYSM; NOTE;

COGNITION DISORDERS; DRUG INTERACTIONS; HUMANS; INTRACRANIAL ANEURYSM; NIMODIPINE; PHENYTOIN; SEIZURES; SUBARACHNOID HEMORRHAGE; VALPROIC ACID;

EID: 33644695519     PISSN: 00392499     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.STR.0000190837.63350.84     Document Type: Letter

References (4)

1. Naidech AM, Kreiter KT, Janjua N, Ostapkovich N, Parra A, Commichau C, Connolly ES, Mayer SA, Fitzsimmons BF. Phenytoin exposure is associated with functional and cognitive disability after subarachnoid haemorrhage. Stroke. 2005;36:583-587.
2. Rinkel GJ, Feigin VL, Algra A, van den Bergh WM, Vermeulen M, van Gijn J. Calcium antagonists for aneurysmal subarachnoid haemorrhage. Cochrane Database Syst Rev. 2005;25:CD000277.
3. Bayer Pharmaceuticals Corporation. Summary of characteristics: Nimotop 30mg tablets. Nimotop/Tablets (30 mg)/SMPC/Approved/UK/SmPC NimTab UK 005_3/DOC.
4. Carney BT, Minter CL. Is operative blood loss associated with valproic acid? Analysis of bilateral femoral osteotomy in children with total involvement cerebral palsy. J Pediatr Orthop. 2005;25:283-285.